Triplex Biological Park,No.2041 Xizhou Road,Xike Town,Tongan District,Xiamen,Fujian,China(361100),Xiamen,Fujian,China China
Founded in 2 0 0 4, Triplex International Biosciences (China) Co.,
Ltd (hereinafter refer to TIB) has become a high-tech biomedical
enterprise integrating the research and development, production and
sales of molecular diagnostic and supporting instruments, as well
as providing high-end medical diagnostic services.
TIB is also a national high-tech enterprise, the executive director
unit of Chinese Union of Translational Medicine and Biotechnology
Alliance, the president unit of Fujian Provincial In vitro
Diagnostic Reagent Industrial Technology Strategic Alliance, and an
outstanding high-tech enterprise in Xiamen.
TIB has been committed to building its own high-end medical
diagnosis research and development highland. It has set up
independent research centers in Beijing, Xiamen and Fuzhou cities
on the basis of the research platforms such as "The State-Local
Joint Engineering Lab for Molecular Diagnosis", "The Fujian
Provincial Engineering Lab for Molecular Diagnosis", "Fujian-Taiwan
Medical Instrument Technology Cooperation Base", etc. TIB has also
cooperatively established joint R&D centers with famous
scientific research institutes in China and abroad, such as "The
TIB-Peking University Laboratory of Molecular Pathology¬ with
Peking University Medical Center, "The School of Life Sciences-TIB
Biomedical Diagnostic Research and Development Center¬ with Xiamen
University Biology Department, "The Fujian Provincial Key
Laboratory of Joint Hepatobiliary Technology Innovation "with
Shanghai Oriental Hepatic Hospital of Second Military Medical
University headed by academician Wu Mengchao and Meng Chao
Hepatobiliary Hospital of Fujian Medical University. In addition,
TIB has carried out extensive R&D cooperation with famous
universities and professional R&D institutions such as Second
Military Medical University, Taipei University of Science and
Technology, Yale University and Columbia University. Through the
extensive Industry-university-research cooperation, TIB has built a
leading high-end medical diagnostic R&D platform in line with
international standards, and has accelerated the pace of
internationalization.
Business Type
Manufacturing
Website
http://www.triplexbio.com/
Year Established
2004
Number of Employees
101-500
Main Markets
Americas,Africa,Asia,Caribbean,America,Europe,Middle East,Oceania,Worldwide
Products / Services
flu a & b rapid test kit, dengue ns1 antigen rapid test kit, cholera antigen o1/o139 rapid test kit, malaria antigen p.f/pan rapid test kit, sars-cov-2 antigen rapid test kit, sars-cov-2 igm/igg rapid test kit (colloidal gold)
Factory Location
China Xiamen
Factory Size
10000 sqm to 250000 sqm
No. of Production Lines
5
Total Annual Purchase Volume
10 - 25 Million USD
No. of R&D Staff
51 - 60 people
Quality Control
In House
Certificates
ISO 13485
Contract Manufacturing
OEM Service Offered ,Design Service Offered,Buyer Label Offered
Registered Capital
More than 100 Million USD
Ownership Type
Corporation Limited Liability Company
Legal Representative / CEO
Li Jing
Export Percentage
30%
Total Annual Sales Volume
25 - 50 Million USD
No. of QC Staff
11 - 20 people
Contact Person
Mr. Jacob
Company
Triplex International Biosciences (China) Co., LTD
Address
Triplex Biological Park,No.2041 Xizhou Road,Xike Town,Tongan District,Xiamen,Fujian,China(361100), Xiamen, Fujian, China
Contact Person Mr. Jacob
Address Triplex Biological Park,No.2041 Xizhou Road,Xike Town,Tongan District,Xiamen,Fujian,China(361100), Xiamen, Fujian, China